IMTH — Innovative Medtech Cashflow Statement
0.000.00%
Last trade - 00:00Consumer DefensivesHighly SpeculativeMicro Cap
- $21.53m
- $22.28m
Annual cashflow statement for Innovative Medtech, fiscal year end - October 31st, USD millions except per share, conversion factor applied.
2010 October 31st | 2011 October 31st | 2012 October 31st | 2013 October 31st | 2014 October 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K/A | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -2.02 | -1.05 | -1.49 | -0.567 | -0.365 |
| Depreciation | |||||
| Amortisation | |||||
| Non-Cash Items | 0.326 | 0.226 | 0.779 | 0.211 | 0.004 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 0.433 | 0.749 | 0.653 | 0.356 | 0.357 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Accrued Expenses | |||||
| Change in Payable / Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Cash from Operating Activities | -0.578 | -0.068 | -0.053 | 0 | -0.004 |
| Other Investing Cash Flow Items | 0 | — | — | — | — |
| Sale of Fixed Assets | |||||
| Cash from Investing Activities | 0 | — | — | — | — |
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 0.594 | 0.051 | 0.053 | 0 | 0.005 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 0.017 | -0.017 | 0 | 0 | 0.001 |